Robuta

https://www.themedicinemaker.com/topics/small-molecules The Medicine Maker | Small Molecules the medicine makersmallmolecules https://themedicinemaker.com/authors/romain-dabre/ The Medicine Maker | Romain Dabre the medicine makerromain https://themedicinemaker.com/issues/2022/articles/dec/take-another-look/ The Medicine Maker | Take Another Look Genentech goes beyond pharmaceutical manufacturing in its work with members of the SMA community, who want to draw gazes with their involvement in the world of... the medicine makertakeanotherlook https://themedicinemaker.com/authors/adrian-wildfire The Medicine Maker | Adrian Wildfire the medicine makeradrianwildfire https://themedicinemaker.com/issues/2024/articles/may/ The Medicine Maker | May the medicine makermay https://themedicinemaker.com/issues/2026/articles/february/gsks-rsv-vaccine-moves-closer-to-china-approval/ The Medicine Maker | GSKs RSV Vaccine Moves Closer to China Approval Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year the medicine makerrsv vaccineto china https://themedicinemaker.com/issues/2025/articles/feb/understanding-the-h5n1-threat/ The Medicine Maker | Understanding the H5N1 Threat With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it? the medicine makerunderstandingthreat https://themedicinemaker.com/issues/2024/articles/nov/mastering-medical-congresses-for-product-launch The Medicine Maker | Mastering Medical Congresses for Product Launch Choosing which medical congresses to target when launching your new medicine requires careful research and a sound strategy. the medicine makermedical congressesmasteringproductlaunch https://themedicinemaker.com/issues/2018/articles/jul/trials-of-a-medicine-maker/ The Medicine Maker | Trials of a Medicine Maker Outsourcing Buffer Management is Smart Thinking the medicine makertrials https://themedicinemaker.com/issues/2024/articles/oct/efpia-signs-up-to-bolster-eu-trade/ The Medicine Maker | EFPIA Signs Up to Bolster EU Trade EFPIA signs joint declaration championing open trade in the EU. the medicine makerup toefpiasignsbolster https://themedicinemaker.com/issues/2026/articles/april/glp-1-analysis-riding-the-wave-of-peptide-innovation/ The Medicine Maker | GLP-1 Analysis: Riding the Wave of Peptide Innovation The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we... the medicine makerglp https://www.themedicinemaker.com/issues/2026/articles/february/why-soft-skills-are-more-important-than-ever-in-life-sciences/ The Medicine Maker | Why Soft Skills are More Important than Ever in Life Sciences We should not only find highly qualified scientists and engineers, but also ensure they are ready to work in a collaborative, respectful, and trusting... the medicine maker https://themedicinemaker.com/authors/eric-byres/ The Medicine Maker | Eric Byres the medicine makereric https://themedicinemaker.com/issues?y=2016 The Medicine Maker | Issues the medicine makerissues https://civicascript.com/coverage/the-medicine-maker/ The Medicine Maker Archives | CivicaScript the medicine makerarchives https://www.themedicinemaker.com/issues/2026/articles/january/does-the-role-of-cdmo-need-to-evolve/ The Medicine Maker | Does the Role of CDMO Need to Evolve In short: Yes, says Mat Minardi, Chief Scientific Officer at Sterling Pharma Solutions the medicine makerneed torolecdmoevolve https://themedicinemaker.com/issues/2023/articles/oct/science-fiction-comes-to-life/ The Medicine Maker | Science Fiction Comes to Life Researchers are working on ways to introduce nanoscale artificial life-forms to viruses with the aim of mimicking the human immune system the medicine makerscience fictioncomeslife https://themedicinemaker.com/authors/laura-kronbetter/ The Medicine Maker | Laura Kronbetter the medicine makerlaura https://themedicinemaker.com/issues/2021/articles/dec/2021-in-review-our-best-videos/ The Medicine Maker | 2021 in Review: Our Best Videos Another year of the pandemic; another year of Zoom calls the medicine makerour bestreviewvideos